The Oncosearch | Oncotarget

MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7 Priority Research Paper

Ri Cui, Taewan Kim, Matteo Fassan, Wei Meng, Hui-Lung Sun, Young-Jun Jeon, Caterina Vicentini, Esmerina Tili, Yong Peng, Aldo Scarpa, Guang Liang, Yong Kui Zhang, Arnab Chakravarti, Carlo M. Croce

Published Aug 19, 2015 · Vol. 6, No. 26 · pp. 21802-21815

Digital PCR analysis of plasma cell-free DNA for non-invasive detection of drug resistance mechanisms in EGFR mutant NSCLC: Correlation with paired tumor samples Research Paper

Hidenobu Ishii, Koichi Azuma, Kazuko Sakai, Akihiko Kawahara, Kazuhiko Yamada, Takaaki Tokito, Isamu Okamoto, Kazuto Nishio, Tomoaki Hoshino

Published Aug 17, 2015 · Vol. 6, No. 31 · pp. 30850-30858

Combinatorial treatment using targeted MEK and SRC inhibitors synergistically abrogates tumor cell growth and induces mesenchymal-epithelial transition in non-small-cell lung carcinoma Research Paper

Kian Ngiap Chua, Li Ren Kong, Wen Jing Sim, Hsien Chun Ng, Weijie Richard Ong, Jean Paul Thiery, Hung Huynh, Boon Cher Goh

Published Aug 17, 2015 · Vol. 6, No. 30 · pp. 29991-30005

An epigenetic auto-feedback loop regulates TGF-Î² type II receptor expression and function in NSCLC Research Paper

Shanzhong Yang, Yong-Jig Cho, Lin Jin, Guandou Yuan, Arunima Datta, Phillip Buckhaults, Pran K. Datta

Published Aug 12, 2015 · Vol. 6, No. 32 · pp. 33237-33252

Twist1-mediated 4E-BP1 regulation through mTOR in non-small cell lung cancer Research Paper

Tangfeng Lv, Qian Wang, Meghan Cromie, Hongbing Liu, Song Tang, Yong Song, Weimin Gao

Published Aug 12, 2015 · Vol. 6, No. 32 · pp. 33006-33018

Automated tumor analysis for molecular profiling in lung cancer Research Paper

Peter W. Hamilton, Yinhai Wang, Clinton Boyd, Jacqueline A. James, Maurice B. Loughrey, Joseph P. Hougton, David P. Boyle, Paul Kelly, Perry Maxwell, David McCleary, James Diamond, Darragh G. McArt, Jonathon Tunstall, Peter Bankhead, Manuel Salto-Tellez

Published Aug 3, 2015 · Vol. 6, No. 29 · pp. 27938-27952

Keywords: Molecular Pathology, Manual Macrodissection, Percentage Tumor, Image Analysis, Digital Pathology.

Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational status Research Paper

Luigi Formisano, Valentina Dâ€™Amato, Alberto Servetto, Simona Brillante, Lucia Raimondo, Concetta Di Mauro, Roberta Marciano, Roberta Clara Orsini, Sandro Cosconati, Antonio Randazzo, Sarah J. Parsons, Nunzia Montuori, Bianca Maria Veneziani, Sabino De Placido, Roberta Rosa, Roberto Bianco

Published Aug 3, 2015 · Vol. 6, No. 28 · pp. 26090-26103

Inhibition of adipose triglyceride lipase (ATGL) by the putative tumor suppressor G0S2 or a small molecule inhibitor attenuates the growth of cancer cells Research Paper

Rachid Zagani, Wissal El-Assaad, Isabelle Gamache, Jose G. Teodoro

Published Jul 31, 2015 · Vol. 6, No. 29 · pp. 28282-28295

IL-6 signaling contributes to cisplatin resistance in non-small cell lung cancer via the up-regulation of anti-apoptotic and DNA repair associated molecules Research Paper

Shanzhou Duan, Ying Tsai, Peter Keng, Yongbing Chen, Soo Ok Lee, Yuhchyau Chen

Published Jul 30, 2015 · Vol. 6, No. 29 · pp. 27651-27660

The BIM deletion polymorphism is a prognostic biomarker of EGFR-TKIs response in NSCLC: A systematic review and meta-analysis Research Paper

Wei Nie, Xia Tao, Hua Wei, Wan-sheng Chen, Bing Li

Published Jul 27, 2015 · Vol. 6, No. 28 · pp. 25696-25700

Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation Research Paper

Chengcao Sun, Shujun Li, Cuili Yang, Ruilin Xue, Yongyong Xi, Liang Wang, Suqing Wang, Qiqiang He, Jie Huang, Songping Xie, Wenyang Jiang, Dejia Li

Published Jul 25, 2015 · Vol. 6, No. 28 · pp. 25533-25574

MiRNA-10a is upregulated in NSCLC and may promote cancer by targeting PTEN Research Paper

Tao Yu, Lei Liu, Jing Li, Mingxia Yan, Hechun Lin, Ying Liu, Dandan Chu, Hong Tu, Aiqin Gu, Ming Yao

Published Jul 22, 2015 · Vol. 6, No. 30 · pp. 30239-30250

The clinical development candidate CCT245737 is an orally active CHK1 inhibitor with preclinical activity in RAS mutant NSCLC and EÂµ-MYC driven B-cell lymphoma Research Paper

Mike I. Walton, Paul D. Eve, Angela Hayes, Alan T. Henley, Melanie R. Valenti, Alexis K. De Haven Brandon, Gary Box, Kathy J. Boxall, Matthew Tall, Karen Swales, Thomas P. Matthews, Tatiana McHardy, Michael Lainchbury, James Osborne, Jill E. Hunter, Neil D. Perkins, G. Wynne Aherne, John C. Reader, Florence I. Raynaud, Suzanne A. Eccles, Ian Collins, Michelle D. Garrett

Published Jul 22, 2015 · Vol. 7, No. 3 · pp. 2329-2342

Tumor necrosis targeted radiotherapy of non-small cell lung cancer using radioiodinated protohypericin in a mouse model Research Paper

Xuejiao Liu, Cuihua Jiang, Dongjian Zhang, Meng Gao, Fei Peng, Dejian Huang, Ziping Sun, Yicheng Ni, Jian Zhang, Zhiqi Yin

Published Jul 21, 2015 · Vol. 6, No. 28 · pp. 26400-26410

Over-expression of ROR2 and Wnt5a cooperatively correlates with unfavorable prognosis in patients with non-small cell lung cancer Research Paper

Chenlin Lu, Xudong Wang, Huijun Zhu, Jian Feng, Songshi Ni, Jianfei Huang

Published Jul 21, 2015 · Vol. 6, No. 28 · pp. 24912-24921

Continuation of epidermal growth factor receptor tyrosine kinase inhibitor treatment prolongs disease control in non-small-cell lung cancers with acquired resistance to EGFR tyrosine kinase inhibitors Research Paper

Qi Chen, Qi Quan, Lingyu Ding, Xiangchan Hong, Ningning Zhou, Ying Liang, Haiying Wu

Published Jul 9, 2015 · Vol. 6, No. 28 · pp. 24904-24911

High copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer Research Paper

Karol Czubak, Marzena Anna Lewandowska, Katarzyna Klonowska, Krzysztof Roszkowski, Janusz Kowalewski, Marek Figlerowicz, Piotr Kozlowski

Published Jun 22, 2015 · Vol. 6, No. 27 · pp. 23399-23416

Keywords: microRNA, DROSHA, DICER1, non-small cell lung cancer NSCLC, amplifications, MLPA

Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer Research Paper

Hao Liu, Yixue Gu, Hongsheng Wang, Jiang Yin, Guopei Zheng, Zhijie Zhang, Minyin Lu, Chenkun Wang, Zhimin He

Published Jun 20, 2015 · Vol. 6, No. 17 · pp. 14913-14925

Are VEGFR-TKIs effective or safe for patients with advanced non-small cell lung cancer? Clinical Research Papers

Shuai Wang, Zhe Yang, Zhou Wang

Published Jun 19, 2015 · Vol. 6, No. 20 · pp. 18206-18223

A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives Review

Alessandro Russo, Tindara Franchina, Giuseppina Rosaria Rita Ricciardi, Antonio Picone, Giuseppa Ferraro, Mariangela ZanghÃ¬, Giuseppe Toscano, Antonio Giordano, Vincenzo Adamo

Published Jun 12, 2015 · Vol. 6, No. 29 · pp. 26814-26825

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7 Priority Research Paper

Digital PCR analysis of plasma cell-free DNA for non-invasive detection of drug resistance mechanisms in EGFR mutant NSCLC: Correlation with paired tumor samples Research Paper

Combinatorial treatment using targeted MEK and SRC inhibitors synergistically abrogates tumor cell growth and induces mesenchymal-epithelial transition in non-small-cell lung carcinoma Research Paper

An epigenetic auto-feedback loop regulates TGF-Î² type II receptor expression and function in NSCLC Research Paper

Twist1-mediated 4E-BP1 regulation through mTOR in non-small cell lung cancer Research Paper

Automated tumor analysis for molecular profiling in lung cancer Research Paper

Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational status Research Paper

Inhibition of adipose triglyceride lipase (ATGL) by the putative tumor suppressor G0S2 or a small molecule inhibitor attenuates the growth of cancer cells Research Paper

IL-6 signaling contributes to cisplatin resistance in non-small cell lung cancer via the up-regulation of anti-apoptotic and DNA repair associated molecules Research Paper

The BIM deletion polymorphism is a prognostic biomarker of EGFR-TKIs response in NSCLC: A systematic review and meta-analysis Research Paper

Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation Research Paper

MiRNA-10a is upregulated in NSCLC and may promote cancer by targeting PTEN Research Paper

The clinical development candidate CCT245737 is an orally active CHK1 inhibitor with preclinical activity in RAS mutant NSCLC and EÂµ-MYC driven B-cell lymphoma Research Paper

Tumor necrosis targeted radiotherapy of non-small cell lung cancer using radioiodinated protohypericin in a mouse model Research Paper

Over-expression of ROR2 and Wnt5a cooperatively correlates with unfavorable prognosis in patients with non-small cell lung cancer Research Paper

Continuation of epidermal growth factor receptor tyrosine kinase inhibitor treatment prolongs disease control in non-small-cell lung cancers with acquired resistance to EGFR tyrosine kinase inhibitors Research Paper

High copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer Research Paper

Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer Research Paper

Are VEGFR-TKIs effective or safe for patients with advanced non-small cell lung cancer? Clinical Research Papers

A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives Review

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7 Priority Research Paper

Digital PCR analysis of plasma cell-free DNA for non-invasive detection of drug resistance mechanisms in EGFR mutant NSCLC: Correlation with paired tumor samples Research Paper

Combinatorial treatment using targeted MEK and SRC inhibitors synergistically abrogates tumor cell growth and induces mesenchymal-epithelial transition in non-small-cell lung carcinoma Research Paper

An epigenetic auto-feedback loop regulates TGF-Î² type II receptor expression and function in NSCLC Research Paper

Twist1-mediated 4E-BP1 regulation through mTOR in non-small cell lung cancer Research Paper

Automated tumor analysis for molecular profiling in lung cancer Research Paper

Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational status Research Paper

Inhibition of adipose triglyceride lipase (ATGL) by the putative tumor suppressor G0S2 or a small molecule inhibitor attenuates the growth of cancer cells Research Paper

IL-6 signaling contributes to cisplatin resistance in non-small cell lung cancer via the up-regulation of anti-apoptotic and DNA repair associated molecules Research Paper

The BIM deletion polymorphism is a prognostic biomarker of EGFR-TKIs response in NSCLC: A systematic review and meta-analysis Research Paper

Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation Research Paper

MiRNA-10a is upregulated in NSCLC and may promote cancer by targeting PTEN Research Paper

The clinical development candidate CCT245737 is an orally active CHK1 inhibitor with preclinical activity in RAS mutant NSCLC and EÂµ-MYC driven B-cell lymphoma Research Paper

Tumor necrosis targeted radiotherapy of non-small cell lung cancer using radioiodinated protohypericin in a mouse model Research Paper

Over-expression of ROR2 and Wnt5a cooperatively correlates with unfavorable prognosis in patients with non-small cell lung cancer Research Paper

Continuation of epidermal growth factor receptor tyrosine kinase inhibitor treatment prolongs disease control in non-small-cell lung cancers with acquired resistance to EGFR tyrosine kinase inhibitors Research Paper

High copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer Research Paper

Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer Research Paper

Are VEGFR-TKIs effective or safe for patients with advanced non-small cell lung cancer? Clinical Research Papers

A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives Review